NCT04707131View on ClinicalTrials.gov

A Study of Single Ascending Dose of LEM-S401 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

July 11, 2022

Primary Completion Date

October 18, 2022

Study Completion Date

February 3, 2023

Conditions
CicatrixScar Prevention
Interventions
DRUG

LEM-S401

siRNA encapsulated in DegradaBALL®

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

Chungbuk National University Hospital, Cheongju-si

Sponsors

Lead Sponsor

Lemonex Inc.
All Listed Sponsors
lead

Lemonex Inc.

INDUSTRY